Business Wire

Solidus Labs Unveils Agentic-Based Compliance: A New Model for Trade Surveillance Operations

22.5.2025 14:00:00 CEST | Business Wire | Press Release

Share

Solidus Labs, the category-definer in trade surveillance and risk monitoring for digital and traditional asset classes, today announced the launch of Agentic-Based Compliance, a groundbreaking model for surveillance operations that leverages a network of AI agents to deliver exponential efficiency, precision, and intelligence across the entire trade surveillance and transaction monitoring investigation lifecycle.

Legacy compliance solutions have failed to keep up with the rapid modernization and growing complexity of global markets. Compliance teams are forced to work with a patchwork of disconnected and expensive tools that fail to deliver results efficiently. According to McKinsey, compliance analysts spend 80% of their time on low or moderate-risk issues, often repetitively resolving false positives or performing menial work. This inefficiency extends to market abuse detection: Despite the enormous resources and efforts invested in compliance technology, firms continue to face enforcement actions for missed manipulation. Research shows that market abuse like insider trading occurs in 20% of mergers and acquisitions and 5% of quarterly earnings announcements in U.S. markets. More broadly, only 4% of Suspicious Activity Reports (SARs) lead to law enforcement investigations. This isn’t a failure of effort - it’s a failure of architecture.

Built on Solidus’ proprietary platform, HALO, Agentic-Based Compliance reimagines how financial institutions detect, investigate, and resolve market abuse risks. It replaces legacy systems and siloed workflows with a unified, intelligence-led architecture powered by autonomous AI agents that augment human analysts and operate across a multi-dimensional risk environment.

“Agentic-Based Compliance is the only way compliance teams can stay ahead of emerging complexities like 24/7 off-platform trading, enhanced retail participation and the heightened risks they carry for cyber-enhanced financial crimes and cross-product and cross-market manipulation,” said Asaf Meir, Founder and Chief Executive of Solidus Labs. “Our vision is simple: Compliance operations should be as scalable, intelligent, and efficient as the markets they’re designed to protect. Solidus’ Agentic-Based Compliance delivers just that, solving for tech sprawl, alert fatigue, talent shortage and surveillance blind spots that cost firms thousands of hours and can reach billions of dollars in losses and fines.”

HALO embeds a fleet of purpose-built AI agents, each designed to streamline a specific stage of the compliance investigation lifecycle — from signal enrichment and alert remediation to model testing, OSINT intelligence feeds, case management, and regulatory reporting.

Born in crypto’s highly fragmented and complex environment, Solidus’ Agentic-Based Compliance is future-proof by design for all asset classes, leading to 20X faster investigations and saving compliance analysts as much as 5 hours of menial work per day. Like all Solidus Labs’ solutions, it was developed in tandem with regulatory feedback - aligning with the current and evolving demands of modern financial markets, including the imperatives of market abuse regulations in the U.S., EU, and other leading jurisdictions.

Poised to power the next generation of surveillance operations, Solidus’ Agentic-Based Compliance is already gaining traction among forward-looking financial firms seeking to modernize their compliance capabilities and reduce operational strain.

To learn more, visit www.soliduslabs.com.

About Solidus Labs

Solidus Labs is the category-definer for Agentic-Based Compliance in trade surveillance and risk monitoring. Founded in 2018 by Goldman Sachs veterans, the company merges Wall Street rigor, crypto-native innovation, and cybersecurity principles to reinvent compliance for the modern financial era. At the core is HALO, an AI-powered risk-based platform trusted by financial institutions, crypto firms, and regulators globally to drive proactive, intelligence-led oversight — across any product, venue, or asset class.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250522186908/en/

Contacts

Trevor Davis
Gregory FCA for Solidus Labs
443.248.0359
trevor@gregoryfca.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FuzeBox AI Named Founding Co-Author of SPUR Coalition Technical Committee on Verifying AI Content Use5.10.2026 15:00:00 CEST | Press Release

FuzeBox AI has been named by the SPUR Coalition, an international nonprofit of 37 news and media organizations, as one of four founding co-authors of its Evidence Profile Technical Committee, adopted Sept. 2, 2026, to draft an evidence profile for SPUR's Content Telemetry standard: a way for publishers to verify AI usage reports without depending on the reporting company's cooperation. Under SPUR's current standard, AI companies self-report their content use. A company that skips reporting leaves no record, and publishers can't check what they do receive. On July 10, 2026, FuzeBox proposed its Verified Provenance Telemetry Standard (VPTS): publishers seed content with detectable markers, then verify their appearance in AI outputs via an auditable ledger, with no change to SPUR's standard. Within 48 hours, three organizations filed related proposals: ProRata on usage magnitude, Encypher CEO Erik Svilich on the verification question FuzeBox raised, and LicenseFoundry on portable proof of

Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 14:02:00 CEST | Press Release

Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty Texture Editwas designed to resonate with a global cultural beauty movement captivating the next gene

GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 14:00:00 CEST | Press Release

GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions, including regulatory approvals, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005273717/en/ SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products The acquisition of SOFIE Biosciences establishes a footprint for GE HealthCare in the time-critical ‘final mile’ of U.S. PET radiopharmaceutical supply, while also enabling PDx to participate in other high growth areas outside its own product portfolio. With a U.S. network of 15 CMO sites operating 21 cyclotrons, and a theranostics

Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 13:24:00 CEST | Press Release

Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking expertise with Solos' proprietary dealcoholization and patented aroma recovery technology. With 30 years of experience in producing alcohol-free sparkling wines, Henkell Fre

Croma-Pharma Expands Its Portfolio in Canada With saypha ® lips Lidocaine and Exprecell™5.10.2026 13:12:00 CEST | Press Release

Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye